As time goes on, we're finding out more and more benefits of sodium glucose co-transporter 2 (SGLT2) inhibitors, said Robert A. Gabbay, MD, PhD, the chief science and medical officer at the American Diabetes Association.
Transcript
In the past decade, we’ve seen the SGLT2 class burst on to the scene, first in type 2 diabetes, and now in heart failure and renal disease. Are you seeing more patients with type 2 diabetes being prescribed these therapies by a cardiologist or nephrologist?
SGLT2 medications have really been a game changer in the world of diabetes, and we're finding out more and more benefits. As you know, this started off as a story about cardiovascular disease, it's now extended to renal disease. One initiative that the American Diabetes Association is leading in collaboration with the American Heart Association, is a program called No Diabetes by Heart. That effort, that has been a 3-year activity by us, aimed at consumers in general, at people with diabetes and at providers and health systems, has been moving the needle. We've done some recent survey data across the country that indicates that, particularly to the target providers that we've been looking at, and that is cardiologists and nephrologists, are more confident and more knowledgeable about these medications, and now increasingly view this as their responsibility to prescribe these medications. So we are seeing progress, but we still have further to go.
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
Joanne Mizell: Lifestyle Modification Programs Take Holistic Aim at Metabolic Disease
May 1st 2024Joanne Mizell shares insurer strategies in addressing the escalating rates of metabolic diseases, highlighting the importance of holistic treatment methods like lifestyle modification programs, which integrate nutrition, physical activity, and community engagement.
Read More
Latest Advances and Updates of Treatment in the Real World at AUA
May 1st 2024The annual meeting of the American Urological Association (AUA) not only presents the newest therapies coming out but showcases the latest in how treatments are being used in the real world, said Stephen Freedland, MD, of Cedars Sinai.
Read More